About Elephas Biosciences
Elephas Biosciences is a private company based in Madison, Wisconsin, incorporated in 2020 in Delaware. It has reported $113,719,017 raised in four offerings on Form D since October 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 30, 2023 | Jan 9, 2024 | $51,218,994of $55.0M target | 10 | $5.1M | EquityRule 506(b) | Form D ↗ |
| Aug 15, 2022 | Sep 14, 2022 | $41,500,023of $43.5M target | 7 | $5.9M | EquityRule 506(b) | Form D ↗ |
| May 21, 2021 | Oct 29, 2021 | $1,000,000fully sold | 17 | $58,824 | EquityRule 506(b) | Form D ↗ |
| Sep 16, 2021 | Oct 14, 2021 | $20,000,000fully sold | 5 | $4.0M | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $113,719,017 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Elephas Biosciences's Form D filed Jan 9, 2024.
SG
Steven Galson
Director
TB
Terrence Brady
Chief Financial Officer
AJ
Andrea Jackson
Director
MA
Maneesh Arora
Executive officer and director
PB
Paul Berns
Director
Earlier filings also listed Michelle Arora (director, last listed Oct 2021) and Jonathan Oliner (executive officer, last listed Oct 2021).